Total raised
$6.0M
Stage
Seed
Founded
2015
Headcount
6
HQ
Jerusalem
Sector
Health Tech & Life Sciences
About
BioNanoSim (BNS) has developed a proprietary technology platform for the nano-encapsulation of drugs to improve delivery profile and therapeutic performance. Research conducted by Professor Simon Benita and his team has demonstrated the potential of BNS's nano-encapsulation technology to design innovative routes of administration across a range of therapeutic areas including oncology, ophthalmology, and metabolic diseases. In addition, BNS is using its nano-encapsulation technologies to develop topical and ocular cannabis-based products.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is BioNanoSim's core technology?
- BioNanoSim (BNS) has developed a proprietary technology platform for the nano-encapsulation of drugs to improve delivery profile and therapeutic performance.
- What therapeutic areas does BioNanoSim's nano-encapsulation technology target?
- BioNanoSim's nano-encapsulation technology is being used to design innovative routes of administration across therapeutic areas including oncology, ophthalmology, and metabolic diseases.
- What cannabis-based products is BioNanoSim developing?
- BioNanoSim is using its nano-encapsulation technologies to develop topical and ocular cannabis-based products.
- When was BioNanoSim founded?
- BioNanoSim was founded in July 2015.
- How many employees does BioNanoSim currently have?
- BioNanoSim currently has 6 employees.
- What is BioNanoSim's total funding raised to date?
- BioNanoSim has raised a total of $6,000,000 USD. For full financing history, refer to startupim.
- Who is a founder of BioNanoSim?
- Simon Benita is a founder of BioNanoSim.
- What is one of BioNanoSim's key products in development?
- One of BioNanoSim's key products is Improved Oxaliplatin (OPA).
- What was a significant technology development for BioNanoSim in 2015?
- In July 2015, BioNanoSim developed a drug-delivery technology that deposits polymeric biodegradable nanoparticles into the body.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical Cannabis
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
pharma-companiescancerpharmaceuticalsnanotechnologydrug-deliveryhealthcare-providerscannabistreatmentsbioconvergence